Boston Scientific To Market Celsion’s Prolieve BPH Device Immediately
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will promote Celsion's Prolieve microwave urethroplasty system as a less-painful alternative to existing treatments for benign prostatic hyperplasia (BPH), following FDA approval Feb. 19